US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novo Nordisk A/S B Shares ADRhedged

21.67

0.0000

Volume:60

Turnover:1.30K

Market Cap:3.68M

PE:- -

High:21.67

Open:21.67

Low:21.67

Close:21.67

52wk High:34.36

52wk Low:19.00

Shares:170.00K

Float Shares:170.00K

Volume Ratio:0.03

T/O Rate:0.04%

Dividend:1.56

Dividend Rate:7.20%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Novo Nordisk price target lowered to DKK 296 from DKK 310 at Citi

Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market

1 Drugs Could Ease Back and Knee Pain, but Doctors Say There are Risks for Older Adults

Novo Nordisk's Wegovy Pill to Buoy Sales, but Investors Likely to Stay Sidelined

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/NVOH"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":21.67,"timestamp":1791569877947,"preClose":21.67,"halted":0,"volume":60,"delay":0,"changeRate":0,"floatShares":170001,"shares":170001,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"10-09 14:46:47 EDT","open":21.67,"high":21.67,"low":21.67,"amount":1302.7379999999998,"amplitude":0,"askPrice":21.76,"askSize":100,"bidPrice":21.67,"bidSize":399,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":21.67,"nav":21.635165,"aum":3677999.685165,"dividendRate":0.071994,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":21.67,"preClose":21.67,"latestTime":"16:15 EDT","volume":8,"amount":173.36,"timestamp":1791490500239,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.032981,"impliedVol":0.2491,"impliedVolPercentile":0.6165},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":170001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.032981,"shares":170001,"dividePrice":1.5601,"high":21.67,"amplitude":0,"preClose":21.67,"low":21.67,"week52Low":19,"pbRate":"--","week52High":34.36,"institutionHeld":0,"latestPrice":21.67,"committee":0.599198,"eps":0,"divideRate":0.071994,"volume":60,"delay":0,"ttmEps":0,"open":21.67,"prevYearClose":27.4362,"prevWeekClose":20.9938,"prevMonthClose":21.2125,"prevQuarterClose":21.2125,"fiveDayClose":20.9938,"twentyDayClose":23.4261,"sixtyDayClose":27.8996},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2026-09-16","symbol":"NVOH","amount":0.02979,"announcedDate":"2026-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-16","defaultRemindTime":1789565400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-23","payableDate":"2026-09-16","currency":"USD","dateTimestamp":1789531200000,"payDate":"2026-09-23"},{"date":"2026-06-16","symbol":"NVOH","amount":0.76666,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"NVOH","amount":0.27495,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.27495,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.76666,"currency":"USD"},{"executeDate":"2026-09-16","recordDate":"2026-09-16","paymentDate":"2026-09-23","value":0.02979,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674286599","title":"Novo Nordisk price target lowered to DKK 296 from DKK 310 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2674286599","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674286599?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:31","pubTimestamp":1791563467,"startTime":"0","endTime":"0","summary":"Citi analyst Graham Parry lowered the firm’s price target on Novo Nordisk (NVO) to DKK 296 from DKK 310 and keeps a Neutral rating on the shares. P...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-price-target-lowered-to-dkk-296-from-dkk-310-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-price-target-lowered-to-dkk-296-from-dkk-310-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVOC","BK4588","BK4585","IE00BKVL7J92.USD","LU1093756325.SGD","OZEM","PPH","IE00BZ1G4Q59.USD","NVOH","THNR","BK4532","BK4599","LU0154236417.USD","LU1093756168.USD","NVOX","NVO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674863271","title":"Novo Nordisk A/S Series B Stock Rises Friday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2674863271","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674863271?lang=en_us&edition=fundamental","pubTime":"2026-10-10 00:03","pubTimestamp":1791561780,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B advanced 2.1% to DKK255.25 Friday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 1.5% to 2,615.74.The company closed DKK154.70 below its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 5,041,888, compared to the 50-day average trading volume of 5,080,254.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","BK4007","THNR","OZEM","LU1093756325.SGD","BK4532","LU0154236417.USD","NVOC","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4588","BK5011","LU1093756168.USD","NVOH","BK4585","NVO","0QIU.UK","BK4599","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674785071","title":"1 Drugs Could Ease Back and Knee Pain, but Doctors Say There are Risks for Older Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2674785071","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674785071?lang=en_us&edition=fundamental","pubTime":"2026-10-09 22:38","pubTimestamp":1791556680,"startTime":"0","endTime":"0","summary":"Losing weight is good for the spine. However, physicians say rapid weight loss can lead to issues with bone quality in certain people.Doctors say that some patients who are taking GLP-1 drugs to lose ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2491049909.HKD","RXL","ILDR","SG9999001176.USD","SGXZ99366536.SGD","LU1917777945.USD","LU0471298777.SGD","LU0471298694.HKD","LU1127390331.HKD","THNR","SG9999014898.SGD","LU0323591593.USD","BK4532","BK4533","LU0094547139.USD","LU0203201768.USD","LU2211815571.USD","LU2023250504.SGD","LU1232071149.USD","PJP","SGXZ51526630.SGD","XLV","IE00BKDWB100.SGD","LU1868836914.USD","LU2361045086.USD","IE0001KFT4U8.USD","LU0787776722.HKD","LU1988902786.USD","LU1979441026.SGD","IE00BFSS7M15.SGD","IE00BFSS8Q28.SGD","BK4588","LU2468319806.SGD","LU2089984988.USD","LU2456880835.USD","IHE","LU0320765992.SGD","FHLC","SG9999018865.SGD","LU1868837136.USD","GDOC","LU2023251221.USD","LU2462591350.SGD","IE0009355771.USD","LU2746668461.USD","SG9999013999.USD","LU2471134952.CNY","SG9999018857.SGD","LU2896262040.SGD","SG9999001176.SGD","LU0225283273.USD","LU2237443465.HKD","GB00BDT5M118.USD","PPH","IE00B1BXHZ80.USD","LU2461242641.AUD","SG9999015945.SGD","SG9999015978.USD","LU0964807845.USD","IE00BKVL7J92.USD","LU0640476718.USD","LU1629891620.HKD","LU2491050071.SGD","SG9999017495.SGD","LU1035775433.USD","LU2168564065.EUR","LU0210536198.USD","LU1093756168.USD","LU2237438978.USD","IE00BJT1NW94.SGD","LU2168564149.EUR","LU2756315664.SGD","LU2750360997.AUD","IE00BJJMRX11.SGD","LLYX","LU1366192091.USD","LU0106261372.USD","BK4516","LU2106854487.HKD","NVOC","IYH","LU0354030511.USD","LU0672654240.SGD","LU1291159041.SGD","LU1868837300.USD","LU2552382215.SGD","LU0320765059.SGD","SG9999014880.SGD","LU1093756325.SGD","LU1804176565.USD","IE00B7KXQ091.USD","LU0889565916.HKD","LU0689472784.USD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU2028103732.USD","LU2089284900.SGD","LU2168564495.EUR","LU2361044865.SGD","LU2089283258.USD","LU0154236417.USD","IE00B2B36J28.USD","LU1989771016.USD","LU2168563687.JPY","LU2264538146.SGD","LU2361044949.HKD","LU0823434583.USD","LU2746668974.SGD","LU2108987350.USD","LU1064131342.USD","IE00B4JS1V06.HKD","IE0002141913.USD","LU1145028129.USD","LU0158827948.USD","LU0417517546.SGD","FTXH","LU2750360641.GBP","MEDX","LU1548497426.USD","HRTS","LU2213496289.HKD","LU1057294990.SGD","LU0058720904.USD","BK4585","LU0353189680.USD","LU2602419157.SGD","SGXZ57979304.SGD","LU2236285917.USD","LU0820562030.AUD","LU1868836757.USD","IE00BZ1G4Q59.USD","LU2471134523.USD","LU2491050154.USD","ELIS","LU2237443622.USD","LU0133085943.USD","IE00B1XK9C88.USD","IE00BJJMRZ35.SGD","LU1720051017.SGD","LU0943347566.SGD","SG9999015986.USD","LLY","LLII","VHT","LU2112291526.USD","LU0820561909.HKD","IE00BJJMRY28.SGD","LU1814569148.SGD","LU0456855351.SGD","LU1691799644.USD","LU0882574055.USD","LLYZ","IE00BK4W5L77.USD","IE00BWXC8680.SGD","LU0234572021.USD","LU0198837287.USD","LU0385154629.USD","LU0114720955.EUR","LU1712237335.SGD","ELIL","LU2168564222.USD","AGNG","WDNA","SG9999014914.USD","LU2087625088.SGD","LU0345770308.USD","LU2471134796.USD","TMED","LU0079474960.USD","BK4581","IE00BN29S564.USD","LU0266013472.USD","LU2023250330.USD","SG9999015952.SGD","LU1720051108.HKD","MHIP","LU0708995401.HKD","LU1061106388.HKD","LU0882574139.USD","LU0238689110.USD","LU1551013425.SGD","LU1868836591.USD","SGXZ31699556.SGD","LU0820561818.USD","LU0466842654.USD","LU1267930730.SGD","LU2063271972.USD","LU0061475181.USD","LU2552382058.USD","LU1983299246.USD","LU2552382132.HKD","IE00BK4W5M84.HKD","LU2111349929.HKD","LU0097036916.USD","LU2237443895.HKD","LU0122379950.USD","LU1623119135.USD","LU0432979614.USD","CURE","LU1323610961.USD","NVOH","IE00BKPKM429.USD","LU1551013342.USD","SG9999014906.USD","LU0203202063.USD","LU1974910355.USD","LU2360106947.USD","SGXZ81514606.USD","LU0345770993.USD","LU0354030438.USD","LU0289739699.SGD","BK4007","MEDI","LU2357305700.SGD","LU2324357040.USD","LU0823416689.USD","LU0109391861.USD","IE0004445015.USD","LU1280957306.USD","LU2417539215.USD","LU2237443382.USD","IE0004445239.USD","LU2462157665.USD","LU2756315318.SGD","LU2237443978.SGD","BK4534","IE00BFTCPJ56.SGD","LU0006306889.USD","LU2265009873.SGD","TRUH","IE0005OL40V9.USD","CANC","NVO","LU2237443549.SGD","LU1069344957.HKD","LU0158827781.USD","LU0174119429.USD","LU2271345857.HKD","IXJ","OZEM","NVOX","LU0256863902.USD","IE00BJLML261.HKD","LU0109394709.USD","LU0823434740.USD","LU0786609619.USD","BK4599","IE00B775H168.HKD","LU0683600562.USD","LU2471134879.HKD","LU0256863811.USD","LU0353189763.USD","LU0316494557.USD","LU0096364046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674832906","title":"Novo Nordisk's Wegovy Pill to Buoy Sales, but Investors Likely to Stay Sidelined","url":"https://stock-news.laohu8.com/highlight/detail?id=2674832906","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674832906?lang=en_us&edition=fundamental","pubTime":"2026-10-09 16:42","pubTimestamp":1791535320,"startTime":"0","endTime":"0","summary":"0842 GMT - Novo Nordisk third-quarter sales could come in just above consensus after the strong Wegovy pill launch in the U.K., Citi analysts write. The bank forecasts sales 1% ahead of consensus, with sales of the Wegovy pill posting a 16% beat, while adjusted operating income is likely to land only in line, due to higher research and development costs which will weigh on margins. While Citi expects a Wegovy pill beat would be welcome, it still sees poor visibility on injectable Wegovy pricing and growing long-term competition threats from Eli Lilly, Roche, Pfizer and AstraZeneca as likely to keep many investors on the sidelines. The bank lowers its target price to 296 Danish kroner from 310 kroner and keeps its neutral rating. Shares rise 1.3% to 253.15 kroner.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOC","THNR","BK4599","BK4588","IE00BKVL7J92.USD","BK4585","NVO","NVOH","IE00BZ1G4Q59.USD","PPH","BK4007","BK4532","LU1093756168.USD","OZEM","LU1093756325.SGD","NVOX","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NVOH\",params:#limit:6,delay:false,,,undefined,":[]}}